Paul K. Audhya
Chief Medical Officer, KalVista Pharmaceuticals, Inc.
Companies
- KalVista Pharmaceuticals, Inc.Chief Medical Officer May 4, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- KalVista Pharmaceuticals, Inc.0 shares2Jun 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Returned to company 150,260 shares of KalVista Pharmaceuticals, Inc.2
- May 26, 2026Sold 2,239 shares at $26.78 of KalVista Pharmaceuticals, Inc.3
- May 22, 2026Sold 2,685 shares at $26.78 of KalVista Pharmaceuticals, Inc.4
- May 22, 2026Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.3
- May 21, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.4
- May 18, 2026Sold 1,032 shares at $26.76 of KalVista Pharmaceuticals, Inc.5
- May 17, 2026Exercised options 2,419 shares of KalVista Pharmaceuticals, Inc.5
- Apr 17, 2026Sold 2,686 shares at $20.22 of KalVista Pharmaceuticals, Inc.6
- Apr 16, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.6
- Feb 23, 2026Sold 5,354 shares at $15.57 of KalVista Pharmaceuticals, Inc.7
- Feb 22, 2026Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.7
- Feb 21, 2026Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.7
- Feb 18, 2026Sold 1,163 shares at $15.00 of KalVista Pharmaceuticals, Inc.8
- Feb 17, 2026Exercised options 2,419 shares of KalVista Pharmaceuticals, Inc.8
- Nov 24, 2025Sold 5,296 shares at $13.45 of KalVista Pharmaceuticals, Inc.9
- Nov 22, 2025Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.9
- Nov 21, 2025Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.9
- Nov 18, 2025Sold 3,075 shares at $14.48 of KalVista Pharmaceuticals, Inc.10
- Nov 17, 2025Exercised options 6,447 shares of KalVista Pharmaceuticals, Inc.10
- Aug 25, 2025Sold 2,336 shares at $13.42 of KalVista Pharmaceuticals, Inc.11
- Aug 22, 2025Sold 2,942 shares at $13.22 of KalVista Pharmaceuticals, Inc.12
- Aug 22, 2025Exercised options 5,000 shares of KalVista Pharmaceuticals, Inc.11
- Aug 21, 2025Exercised options 6,250 shares of KalVista Pharmaceuticals, Inc.12
- Aug 18, 2025Sold 2,939 shares at $13.19 of KalVista Pharmaceuticals, Inc.13
- Aug 17, 2025Exercised options 6,446 shares of KalVista Pharmaceuticals, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 27, 2026
- 4SEC EDGARForm 4 filed May 26, 2026
- 5SEC EDGARForm 4 filed May 19, 2026
- 6SEC EDGARForm 4 filed Apr 20, 2026
- 7SEC EDGARForm 4 filed Feb 24, 2026
- 8SEC EDGARForm 4 filed Feb 19, 2026
- 9SEC EDGARForm 4 filed Nov 26, 2025
- 10SEC EDGARForm 4 filed Nov 19, 2025
- 11SEC EDGARForm 4 filed Aug 26, 2025
- 12SEC EDGARForm 4 filed Aug 25, 2025
- 13SEC EDGARForm 4 filed Aug 19, 2025